Source: International Immunopharmacology. Unidade: FMRP
Subjects: HEPATITE, CITOTOXICIDADE IMUNOLÓGICA, CITOCINAS, INTERFERONS
ABNT
NICOLETE, Larissa Deadame de Figueiredo et al. Hepatitis delta: in vitro evaluation of cytotoxicity and cytokines involved in PEG-IFN therapy. International Immunopharmacology, v. 91, p. 1-4, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.intimp.2020.107302. Acesso em: 17 nov. 2024.APA
Nicolete, L. D. de F., Cunha, C. V., Tavanez, J. P., Pinto, M. T., Rodrigues, E. S., Kashima, S., et al. (2021). Hepatitis delta: in vitro evaluation of cytotoxicity and cytokines involved in PEG-IFN therapy. International Immunopharmacology, 91, 1-4. doi:10.1016/j.intimp.2020.107302NLM
Nicolete LD de F, Cunha CV, Tavanez JP, Pinto MT, Rodrigues ES, Kashima S, Covas DT, Villalobos-Salcedo JM, Nicolete R. Hepatitis delta: in vitro evaluation of cytotoxicity and cytokines involved in PEG-IFN therapy [Internet]. International Immunopharmacology. 2021 ; 91 1-4.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.intimp.2020.107302Vancouver
Nicolete LD de F, Cunha CV, Tavanez JP, Pinto MT, Rodrigues ES, Kashima S, Covas DT, Villalobos-Salcedo JM, Nicolete R. Hepatitis delta: in vitro evaluation of cytotoxicity and cytokines involved in PEG-IFN therapy [Internet]. International Immunopharmacology. 2021 ; 91 1-4.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.intimp.2020.107302